76
|
Lepelletier C, De Menthon M, Haroche J, Moachon L, Meignin V, Bouaziz JD, Mahr A. DRESS syndrome induit par le vémurafénib chez une patiente atteinte d’une histiocytose mixte. Ann Dermatol Venereol 2014. [DOI: 10.1016/j.annder.2014.09.588] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
77
|
Abbara S, Chapelon-Abric C, Haroche J, Benveniste O, Papo T, Mathian A, Cottin V, Amoura Z, Valeyre D, Aubart FC. Atteintes musculaires au cours de la sarcoïdose : étude multicentrique chez 47 patients. Rev Med Interne 2014. [DOI: 10.1016/j.revmed.2014.10.121] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
78
|
Letertre-Gibert P, Mania A, Haroche J, Andre M, Aumaître O. Coliques néphrétiques à répétition : une imagerie à passer au peigne fin ! Rev Med Interne 2014. [DOI: 10.1016/j.revmed.2014.10.292] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
79
|
Jouenne R, Chader D, Cohen Aubart F, Haroche J, Mathian A, Musset L, Gorochov G, Amoura Z, Miyara M. Réponse des lymphocytes T régulateurs à des hautes doses de méthylprednisolone au cours du lupus systémique. Rev Med Interne 2014. [DOI: 10.1016/j.revmed.2014.10.053] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
80
|
Chasset F, Barete S, Arnaud L, Le pelletier F, Charlotte F, Emile JF, Amoura Z, Francès C, Haroche J. Manifestations dermatologiques de la maladie d’Erdheim-Chester. Ann Dermatol Venereol 2014. [DOI: 10.1016/j.annder.2014.09.126] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
81
|
Arnaud L, Mathian A, Adoue D, Bader-Meunier B, Baudouin V, Belizna C, Bonnotte B, Boumedine F, Chaib A, Chauchard M, Chiche L, Daugas E, Ghali A, Gobert P, Gondran G, Guettrot-Imbert G, Hachulla E, Hamidou M, Haroche J, Hervier B, Hummel A, Jourde-Chiche N, Korganow AS, Kwon T, Le Guern V, Le Quellec A, Limal N, Magy-Bertrand N, Marianetti-Guingel P, Martin T, Martin Silva N, Meyer O, Miyara M, Morell-Dubois S, Ninet J, Papo T, Pennaforte JL, Polomat K, Pourrat J, Queyrel V, Raymond I, Remy P, Sacre K, Schmidt J, Sibilia J, Viallard JF, Viau Brabant A, Wahl D, Bruckert E, Amoura Z. [Screening and management of cardiovascular risk factors in systemic lupus erythematosus: Recommendations for clinical practice based on the literature and expert opinion]. Rev Med Interne 2014; 36:372-80. [PMID: 25455954 DOI: 10.1016/j.revmed.2014.10.009] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/05/2013] [Revised: 04/17/2014] [Accepted: 10/13/2014] [Indexed: 11/28/2022]
Abstract
PURPOSE To develop French recommendations about screening and management of cardiovascular risk factors in systemic lupus erythematosus (SLE). METHODS Thirty-nine experts qualified in internal medicine, rheumatology and nephrology have selected recommendations from a list developed based on evidence from the literature. For each recommendation, the level of evidence and the level of agreement among the experts were specified. RESULTS Experts recommended an annual screening of cardiovascular risk factors in SLE. Statins should be prescribed for primary prevention in SLE patients based on the level of LDL-cholesterol and the number of cardiovascular risk factors, considering SLE as an additional risk factor. For secondary prevention, experts have agreed on an LDL-cholesterol target of <0.7 g/L. Hypertension should be managed according to the 2013 European guidelines, using renin-angiotensin system blockers as first line agents in case of renal involvement. Aspirin can be prescribed in patients with high cardiovascular risk or with antiphospholipid antibodies. CONCLUSION These recommendations about the screening and management of cardiovascular risk factors in SLE can be expected to improve clinical practice uniformity and, in the longer term, to optimize the management of SLE patients.
Collapse
|
82
|
Haroche J, Cohen-Aubart F, Arnaud L, Hervier B, Charlotte F, Drier A, Gorochov G, Grenier P, Cluzel P, Maksud P, Emile JF, Amoura Z. Maladie d’Erdheim-Chester. Rev Med Interne 2014; 35:715-22. [DOI: 10.1016/j.revmed.2014.04.007] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2013] [Revised: 01/14/2014] [Accepted: 04/14/2014] [Indexed: 10/25/2022]
|
83
|
Cohen-Aubart F, Emile JF, Maksud P, Galanaud D, Idbaih A, Chauvet D, Amar Y, Benameur N, Amoura Z, Haroche J. Marked efficacy of vemurafenib in suprasellar Erdheim-Chester disease. Neurology 2014; 83:1294-6. [DOI: 10.1212/wnl.0000000000000832] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
84
|
Arnaud L, Serio I, Hié M, Levy R, Mathian A, Haroche J, Aubart F, Boutin D, Amoura Z. Syndrome d’activation macrophagique au cours du lupus systémique : étude monocentrique de 37 épisodes survenus chez 29 patients. Rev Med Interne 2014. [DOI: 10.1016/j.revmed.2014.03.077] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
85
|
Mathian A, Devilliers H, Miyara M, Parizot C, Arnaud L, Boutin-Le Thi Huong D, Costedoat-Chalumeau N, Haroche J, Autran B, Rozenberg F, Gorochov G, Amoura Z. L’augmentation des lymphocytes T activés CD4+FoxP3+ prédit la mauvaise immunogénicité du vaccin contre la grippe au cours du lupus systémique. Rev Med Interne 2014. [DOI: 10.1016/j.revmed.2014.03.038] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
86
|
Lefaucheur R, Maltete D, Haroche J, Borden A, Wallon D, Bourre B. Teaching NeuroImages: Ataxia and diabetes insipidus. Neurology 2013; 81:e19. [DOI: 10.1212/wnl.0b013e31829bfe0a] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
87
|
Haroche J, Cohen-Aubart F, Arnaud L, Hervier B, Saadoun D, Costedoat-Chalumeau N, Besnard S, Ly KH, Pavic M, Baudet A, Raffray L, Amoura Z. Maladie d’Erdheim-Chester : étude monocentrique de 96 patients. Rev Med Interne 2013. [DOI: 10.1016/j.revmed.2013.03.319] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
88
|
Ebbo M, Grados A, Gobert D, Bernard F, Palat S, Haroche J, Godeau B, Costedoat-Chalumeau N, Papo T, Hamidou M, Harlé JR, Schleinitz N. Intérêt du 18FDG TEP/TDM dans le bilan d’extension et l’évaluation de la réponse au traitement au cours de la maladie associée aux IgG4 : étude rétrospective multicentrique. Rev Med Interne 2013. [DOI: 10.1016/j.revmed.2013.03.294] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
89
|
Cohen Aubart F, Arnaud L, Hervier B, Besnard S, Barete S, Graffin B, Lifermann F, Ory JP, Hoang Xuan K, Benameur N, Amoura Z, Haroche J. Efficacité à moyen terme du vémurafénib dans la maladie d’Erdheim–Chester. Rev Med Interne 2013. [DOI: 10.1016/j.revmed.2013.03.321] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
90
|
Haroche J. SP0031 Erdheim-chester disease. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2012-eular.1506] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
91
|
Henriquez S, Tcherakian C, Roumier M, Sené T, Marroun I, Ackermann F, Haroche J, Bletry O, Kahn JE. Hypertension artérielle pulmonaire induite par l’interféron au cours d’une maladie d’Erdheim-Chester. Rev Med Interne 2013. [DOI: 10.1016/j.revmed.2013.03.181] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
92
|
Thomas G, Cohen Aubart F, Chiche L, Haroche J, Hervier B, Hie M, Mazodier K, Ebbo M, Kaplanski G, Costedoat-Chalumeau N, Harle JR, Amoura Z. Myocardites lupiques : étude du pronostic à long terme dans une série multicentrique. Rev Med Interne 2013. [DOI: 10.1016/j.revmed.2013.03.305] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
93
|
Cazenave M, Mathian A, Arnaud L, Costedoat-Chalumeau N, Boutin-Le Thi Huong D, Chaib A, Cohen-Aubart F, Haroche J, Hervier B, Miyara M, Cluzel P, Amoura Z. Biopsie rénale par voie transjugulaire dans le lupus systémique et le syndrome des antiphospholipides. Rev Med Interne 2013. [DOI: 10.1016/j.revmed.2013.03.302] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
94
|
Cohen Aubart F, Haroche J, Mathian A, Hie M, Miyara M, Arnaud L, Valeyre D, Boutin-Le Thi Huong D, Amoura Z. Traitement par infliximab des neurosarcoïdoses réfractaires : résultats à long terme. Rev Med Interne 2013. [DOI: 10.1016/j.revmed.2013.03.277] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
95
|
Castellano G, Cafiero C, Divella C, Sallustio F, Gigante M, Gesualdo L, Kirsch AH, Smaczny N, Riegelbauer V, Sedej S, Hofmeister A, Stojakovic T, Brodmann M, Pilger E, Rosenkranz A, Eller K, Eller P, Meier P, Lucisano S, Arena A, Donato V, Fazio MR, Santoro D, Buemi M, Wornle M, Ribeiro A, Koppel S, Pircher J, Czermak T, Merkle M, Rupanagudi K, Kulkarni OP, Lichtnekert J, Darisipudi MN, Mulay SR, Schott B, Hartmann G, Anders HJ, Pletinck A, Glorieux G, Schepers E, Van Landschoot M, Eloot S, Van Biesen W, Vanholder R, Castoldi A, Oliveira V, Amano M, Aguiar C, Caricilli A, Vieira P, Burgos M, Hiyane M, Festuccia W, Camara N, Djudjaj S, Rong S, Lue H, Bajpai A, Klinkhammer B, Moeller M, Floege J, Bernhagen J, Ostendorf T, Boor P, Wornle M, Ribeiro A, Koppel S, Merkle M, Ito S, Aoki R, Hamada K, Edamatsu T, Itoh Y, Osaka M, Yoshida M, Oliva E, Maritati F, Palmisano A, Alberici F, Buzio C, Vaglio A, Grabulosa C, Cruz E, Carvalho J, Manfredi S, Canziani M, Cuppari L, Quinto B, Batista M, Cendoroglo M, Dalboni M, Wornle M, Ribeiro A, Merkle M, Niemir Z, Swierzko A, Polcyn-Adamczak M, Cedzynski M, Sokolowska A, Szala A, Baudoux T, Hougardy JM, Pozdzik A, Antoine MH, Husson C, De Prez E, Nortier J, Ni HF, Chen JF, Zhang MH, Pan MM, Liu BC, Machcinska M, Bocian K, Korczak-Kowalska G, Tami Amano M, Castoldi A, Andrade-Oliveira V, da Silva M, Miyagi MYS, Olsen Camara N, Xu L, Jin Y, Zhong F, Liu J, Dai Q, Wang W, Chen N, Grosjean F, Tribioli C, Esposito V, Catucci D, Azar G, Torreggiani M, Merlini G, Esposito C, Fell LH, Zawada AM, Rogacev KS, Seiler S, Fliser D, Heine GH, Neprintseva N, Tchebotareva N, Bobkova I, Kozlovskaya L, Virzi GM, Brocca A, de Cal M, Bolin C, Vescovo G, Ronco C, Fuchs A, Eidenschink K, Steege A, Fellner C, Bollheimer C, Gronwald W, Schroeder J, Banas B, Banas MC, Zawada AM, Luthe A, Seiler SS, Rogacev K, Fliser D, Heine GH, Trimboli D, Graziani G, Haroche J, Lupica R, Fazio MR, Lucisano S, Donato V, Cernaro V, Montalto G, Pettinato G, Buemi M, Cho E, Lee JW, Kim MG, Jo SK, Cho WY, kim HK. Immune and inflammatory mechanisms. Nephrol Dial Transplant 2013. [DOI: 10.1093/ndt/gft142] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
96
|
Mathian A, Devilliers H, Krivine A, Costedoat-Chalumeau N, Haroche J, Huong DBLT, Wechsler B, Hervier B, Miyara M, Morel N, Le Corre N, Arnaud L, Piette JC, Musset L, Autran B, Rozenberg F, Amoura Z. Factors influencing the efficacy of two injections of a pandemic 2009 influenza A (H1N1) nonadjuvanted vaccine in systemic lupus erythematosus. ACTA ACUST UNITED AC 2013; 63:3502-11. [PMID: 21811996 DOI: 10.1002/art.30576] [Citation(s) in RCA: 39] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Abstract
OBJECTIVE To assess the factors influencing the efficacy of 2 injections of a pandemic 2009 influenza A (H1N1) vaccine in patients with systemic lupus erythematosus (SLE). METHODS We conducted a single-center, observational prospective study of 111 patients who were vaccinated with a monovalent, inactivated, nonadjuvanted, split-virus vaccine during December 2009 and January 2010 and received a second dose of vaccine 3 weeks later. The antibody response was evaluated using the hemagglutination inhibition assay according to the guidelines recommended for the pandemic vaccine, consisting of 3 immunogenicity criteria (i.e., a seroprotection rate of 70%, a seroconversion rate of 40%, and a geometric mean ratio [GMR] of 2.5). RESULTS The 3 immunogenicity criteria were met on day 42 (seroprotection rate 80.0% [95% confidence interval (95% CI) 72.5-87.5%], seroconversion rate 71.8% [95% CI 63.4-80.2%], and GMR 10.3 [95% CI 2.9-14.2]), while only 2 criteria were met on day 21 (seroprotection rate 66.7% [95% CI 57.9-75.4%], seroconversion rate 60.4% [95% CI 51.3-69.5%], and GMR 8.5 [95% CI 3.2-12.0]). The vaccine was well tolerated. Disease activity, assessed by the Safety of Estrogens in Lupus Erythematosus National Assessment version of the SLE Disease Activity Index, the British Isles Lupus Assessment Group score, and the Systemic Lupus Activity Questionnaire, did not increase. In the multivariate analysis, vaccination failure was significantly associated with immunosuppressive treatment or a lymphocyte count of ≤ 1.0 × 10⁹/liter. The second injection significantly increased the immunogenicity in these subgroups, but not high enough to fulfill the seroprotection criterion in patients receiving immunosuppressive treatment. CONCLUSION Our findings indicate that the efficacy of the vaccine was impaired in patients who were receiving immunosuppressive drugs or who had lymphopenia. A second injection increased vaccine immunogenicity without reaching all efficacy criteria for a pandemic vaccine in patients receiving an immunosuppressive agent. These results open possibilities for improving anti-influenza vaccination in SLE.
Collapse
|
97
|
Charlotte F, Haroche J, Arnaud L, Von Deimling A, Hélias-Rodzewicz Z, Hervier B, Cohen F, Launay D, Lesot A, Mokhtari K, Canioni D, Galmiche L, Rose C, Schmalzing M, Croockewit S, Kambouchner M, Copin MC, Fraitag S, Sahm F, Brousse N, Amoura Z, Donadieu J, Emile JF. La fréquence des mutations de BRAF est élevée dans les histiocytoses de Langerhans et d’Erdheim-Chester, mais nulle dans les autres histiocytoses. Ann Pathol 2012. [DOI: 10.1016/j.annpat.2012.09.166] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
98
|
Néel A, Artifoni M, Fontenoy AM, Haroche J, Tazi A, Hello M, Agard C, Hamidou M. Histiocytose langerhansienne de l’adulte traitée par cladribine (2-CdA) : analyse de 50 observations. Rev Med Interne 2012. [DOI: 10.1016/j.revmed.2012.03.113] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
99
|
Cohen-Aubart F, Arnaud L, Hervier B, Saadoun D, Amoura Z, Haroche J. L’anakinra, antagoniste du récepteur de l’IL1, est peu efficace dans le traitement de la maladie d’Erdheim-Chester : résultats d’une étude prospective ouverte de huit patients traités pendant 15 mois. Rev Med Interne 2012. [DOI: 10.1016/j.revmed.2012.03.114] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
100
|
Aboab J, Mathian A, Costedoat-Chalumeau N, Cacoub P, Hervier B, Sene D, Haroche J, Piette JC, Amoura Z. Thromboses veineuses cérébrales au cours du syndrome des antiphospholipides : à propos de 16 observations. Rev Med Interne 2012. [DOI: 10.1016/j.revmed.2012.03.063] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|